Von Hoff D D, Cowan J, Harris G, Reisdorf G
Cancer Chemother Pharmacol. 1981;6(3):265-71. doi: 10.1007/BF00256979.
The human tumor cloning system is a soft agar technique which allows the growth of human tumors in vitro. We report here our experience with culturing 2,365 patients' tumors in the system. Overall 1,844 (78%) have formed colonies in vitro. However, only 51% have formed greater than or equal to 30 colonies per 500,000 cells plated. Despite the limitations of inadequate growth for some tumors there are a number of clinical applications for the system, which are reported here. These include: (1) Use of the system to predict for sensitivity of an individual patient's tumor to a particular chemotherapeutic agent; (2) screening new anticancer agents to predict for in vivo activity; 3) monitoring patients' bone marrows for tumor involvement; and (4) use of the number of colonies which form in the assay as a prognostic factor for survival. All of these clinical applications are in their infancy of development and will require carefully designed prospective trials to determine the final place of the human tumor cloning system in the practice of clinical oncology.
人肿瘤克隆系统是一种软琼脂技术,可使人类肿瘤在体外生长。我们在此报告我们在该系统中培养2365例患者肿瘤的经验。总体而言,1844例(78%)在体外形成了集落。然而,每接种500000个细胞,只有51%形成了大于或等于30个集落。尽管该系统对某些肿瘤的生长支持不足,但该系统仍有许多临床应用,在此进行报告。这些应用包括:(1)利用该系统预测个体患者肿瘤对特定化疗药物的敏感性;(2)筛选新的抗癌药物以预测其体内活性;(3)监测患者骨髓是否有肿瘤累及;(4)将试验中形成的集落数量用作生存的预后因素。所有这些临床应用都尚处于发展初期,需要精心设计的前瞻性试验来确定人肿瘤克隆系统在临床肿瘤学实践中的最终地位。